2nd Fluid and Imaging Biomarkers and Endpoints in Neuroscience Summit 2024
Evvnt Promotion / evvnt
Archiv
22.10.2024 - 24.10.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Kongressthemen
Accelerating More Sensitive, Quantitative and Predictive Serological and Imaging Biomarkers to Transform Clinical Development in the CNS.
With the Donanemab ADCOM hailing fluid biomarkers as a deciding factor in the unanimous decision, improved plasma ptau 217 markers and PET tracers, and α-syn self-seeding assay sensitivity and enhancing NFL utility beyond SOD-1 ALS, 2024 has opened the floodgates for biomarker innovation.
Accelerating More Sensitive, Quantitative and Predictive Serological and Imaging Biomarkers to Transform Clinical Development in the CNS.
With the Donanemab ADCOM hailing fluid biomarkers as a deciding factor in the unanimous decision, improved plasma ptau 217 markers and PET tracers, and α-syn self-seeding assay sensitivity and enhancing NFL utility beyond SOD-1 ALS, 2024 has opened the floodgates for biomarker innovation.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2542184-3?pid=4832
Speakers: Aarti Narang, Biomarker Clinical Assay Lead, Pfizer, Bradford Navia, Chief Medical Officer, Aprinoia Therapeutics Inc., and more
URL:
Brochure: https://go.evvnt.com/2542184-3?pid=4832
Speakers: Aarti Narang, Biomarker Clinical Assay Lead, Pfizer, Bradford Navia, Chief Medical Officer, Aprinoia Therapeutics Inc., and more
Anfragen und Anmeldung:
https://go.evvnt.com/2542184-2?pid=4832
Frau Erin Thomas
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
